• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大急诊科患者发生药物不良反应后再次暴露于致病药物:一项队列研究。

Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study.

机构信息

Department of Emergency Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Pharmacoepidemiol Drug Saf. 2024 Sep;33(9):e70012. doi: 10.1002/pds.70012.

DOI:10.1002/pds.70012
PMID:39300754
Abstract

PURPOSE

The magnitude of repeat exposures to culprit medications after hospital discharge is not well studied. We combined prospective cohort data with administrative health data to understand the frequency of repeat exposures to culprit medications after discharge and the risk factors for their occurrence.

METHODS

This was a retrospective analysis of three prospective cohorts of patients who presented to the hospital with an adverse drug event in British Columbia, from 2008 to 2015 (n = 849). We linked prospectively identified adverse drug events to administrative data to examine patterns of redispensing of culprit medications. We used Cox regression to assess risk factors for re-exposure, and conducted subgroup analyses for essential vs. nonessential medications.

RESULTS

Among 849 diagnosed adverse drug events, 45.2% had subsequent culprit medication redispensing within a year of hospital discharge. The factors associated with re-exposures included atrial fibrillation, adverse drug event type (e.g. adverse reaction), culprit medication type, and longer historical duration of medication use.

CONCLUSIONS

Re-exposures to culprit medications occurred in almost half of the adverse drug events diagnosed in emergency departments. Many of these were appropriate re-exposures to essential medications for indications in which the risk of uncontrolled disease likely outweighed the risk of a repeat adverse event. More research is needed to understand re-exposures to nonessential medications or medications with safer alternatives.

摘要

目的

出院后反复暴露于致病药物的程度尚未得到充分研究。我们结合前瞻性队列数据和行政健康数据,了解出院后重复暴露于致病药物的频率及其发生的危险因素。

方法

这是对 2008 年至 2015 年不列颠哥伦比亚省因药物不良反应就诊的三个前瞻性队列的患者进行的回顾性分析(n=849)。我们将前瞻性确定的药物不良反应与行政数据进行了关联,以检查致病药物再调配的模式。我们使用 Cox 回归评估再暴露的危险因素,并对必需药物与非必需药物进行亚组分析。

结果

在 849 例确诊的药物不良反应中,45.2%在出院后一年内有后续的致病药物再调配。与再暴露相关的因素包括心房颤动、药物不良反应类型(如不良反应)、致病药物类型以及更长的药物使用历史时长。

结论

在急诊科诊断的药物不良反应中,几乎有一半发生了再次暴露于致病药物。其中许多是对必需药物的合理再暴露,因为在这些情况下,疾病失控的风险很可能超过再次发生不良反应的风险。需要进一步研究来了解非必需药物或具有更安全替代品的药物的再暴露情况。

相似文献

1
Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study.加拿大急诊科患者发生药物不良反应后再次暴露于致病药物:一项队列研究。
Pharmacoepidemiol Drug Saf. 2024 Sep;33(9):e70012. doi: 10.1002/pds.70012.
2
Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events.验证加拿大行政数据中诊断代码在识别药物不良事件中的使用。
Br J Clin Pharmacol. 2024 Jul;90(7):1688-1698. doi: 10.1111/bcp.16067. Epub 2024 Apr 11.
3
Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study.评估急诊科行政数据中的药物不良事件报告:一项验证研究。
BMC Health Serv Res. 2013 Nov 12;13:473. doi: 10.1186/1472-6963-13-473.
4
Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial.使用 ActionADE 来创建信息连续性,以减少有害药物的再次暴露:一项随机对照试验的研究方案。
Trials. 2021 Feb 5;22(1):119. doi: 10.1186/s13063-021-05061-7.
5
Validating methods used to identify non-adherence adverse drug events in Canadian administrative health data.验证用于识别加拿大行政健康数据中药物不依从性不良药物事件的方法。
Br J Clin Pharmacol. 2024 May;90(5):1240-1246. doi: 10.1111/bcp.16014. Epub 2024 Feb 6.
6
Both New and Chronic Potentially Inappropriate Medications Continued at Hospital Discharge Are Associated With Increased Risk of Adverse Events.新的和慢性潜在不适当药物在出院时持续使用与不良事件风险增加相关。
J Am Geriatr Soc. 2020 Jun;68(6):1184-1192. doi: 10.1111/jgs.16413. Epub 2020 Mar 31.
7
Impact of early in-hospital medication review by clinical pharmacists on health services utilization.临床药师早期院内药物审查对医疗服务利用的影响。
PLoS One. 2017 Feb 13;12(2):e0170495. doi: 10.1371/journal.pone.0170495. eCollection 2017.
8
Repeat adverse drug events associated with outpatient medications: a descriptive analysis of 3 observational studies in British Columbia, Canada.与门诊用药相关的反复出现的药物不良事件:对加拿大不列颠哥伦比亚省3项观察性研究的描述性分析。
CMAJ Open. 2019 Jul 18;7(3):E446-E453. doi: 10.9778/cmajo.20180190. Print 2019 Jul-Sep.
9
Characterizing and Comparing Adverse Drug Events Documented in 2 Spontaneous Reporting Systems in the Lower Mainland of British Columbia, Canada: Retrospective Observational Study.描述和比较不列颠哥伦比亚省低陆平原地区两个自发报告系统中记录的药物不良事件:回顾性观察研究。
JMIR Hum Factors. 2024 Jan 18;11:e52495. doi: 10.2196/52495.
10
Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.医院和社区药剂师之间共享药品不良反应报告以告知重新配药:报告和流程结果分析。
Drug Saf. 2023 Nov;46(11):1161-1172. doi: 10.1007/s40264-023-01348-7. Epub 2023 Oct 2.

引用本文的文献

1
Developing a SNOMED CT-Based Value Set to Document Symptoms and Diagnoses for Adverse Drug Events: Mixed Methods Study.开发基于SNOMED CT的价值集以记录药品不良事件的症状和诊断:混合方法研究
JMIR Med Inform. 2025 Jul 8;13:e70167. doi: 10.2196/70167.
2
Developing and implementing a new health information technology innovation to improve patient safety in the Canadian context.在加拿大背景下开发并实施一项新的健康信息技术创新,以提高患者安全。
Healthc Manage Forum. 2025 Jun 5;38(5):8404704251346951. doi: 10.1177/08404704251346951.